🔗 Visit the ClinicalTrials.gov page for NCT01130805
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Trial watch: Chemotherapy with immunogenic cell death inducers. | Oncoimmunology | 2012 | 1.33 |
| 2 | Current status of novel agents in advanced gastroesophageal adenocarcinoma. | J Gastrointest Oncol | 2015 | 0.83 |
| 3 | New advances in targeted gastric cancer treatment. | World J Gastroenterol | 2016 | 0.81 |
| 4 | Gastric cancer: The times they are a-changin'. | World J Gastrointest Oncol | 2015 | 0.79 |
| 5 | Prospective phase II trial of pazopanib plus CapeOX (capecitabine and oxaliplatin) in previously untreated patients with advanced gastric cancer. | Oncotarget | 2016 | 0.76 |
| 6 | Value of FGFR2 expression for advanced gastric cancer patients receiving pazopanib plus CapeOX (capecitabine and oxaliplatin). | J Cancer Res Clin Oncol | 2016 | 0.75 |